These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149. TWEAK and Fn14 are overexpressed in immune-mediated necrotizing myopathy: implications for muscle damage and repair. Yang M; Ge H; Ji S; Li Y; Xu L; Bi Z; Bu B Rheumatology (Oxford); 2023 Nov; 62(11):3732-3741. PubMed ID: 36916753 [TBL] [Abstract][Full Text] [Related]
150. TWEAK and Fn14 expression in the pathogenesis of joint inflammation and bone erosion in rheumatoid arthritis. Dharmapatni AA; Smith MD; Crotti TN; Holding CA; Vincent C; Weedon HM; Zannettino AC; Zheng TS; Findlay DM; Atkins GJ; Haynes DR Arthritis Res Ther; 2011 Mar; 13(2):R51. PubMed ID: 21435232 [TBL] [Abstract][Full Text] [Related]
151. DNA methyltransferase 3a and mitogen-activated protein kinase signaling regulate the expression of fibroblast growth factor-inducible 14 (Fn14) during denervation-induced skeletal muscle atrophy. Tajrishi MM; Shin J; Hetman M; Kumar A J Biol Chem; 2014 Jul; 289(29):19985-99. PubMed ID: 24895120 [TBL] [Abstract][Full Text] [Related]
152. Targeting fibroblast growth factor (FGF)-inducible 14 (Fn14) for tumor therapy. Zaitseva O; Hoffmann A; Otto C; Wajant H Front Pharmacol; 2022; 13():935086. PubMed ID: 36339601 [TBL] [Abstract][Full Text] [Related]
153. The TWEAK/Fn14/CD163 axis-implications for metabolic disease. Ratajczak W; Atkinson SD; Kelly C Rev Endocr Metab Disord; 2022 Jun; 23(3):449-462. PubMed ID: 34542797 [TBL] [Abstract][Full Text] [Related]
154. Oncoprotein Bmi-1 renders apoptotic resistance to glioma cells through activation of the IKK-nuclear factor-kappaB Pathway. Li J; Gong LY; Song LB; Jiang LL; Liu LP; Wu J; Yuan J; Cai JC; He M; Wang L; Zeng M; Cheng SY; Li M Am J Pathol; 2010 Feb; 176(2):699-709. PubMed ID: 20035051 [TBL] [Abstract][Full Text] [Related]
155. Tumor necrosis factor-like weak inducer of apoptosis and its potential roles in lupus nephritis. Liu ZC; Zhou QL Inflamm Res; 2012 Apr; 61(4):277-84. PubMed ID: 22297307 [TBL] [Abstract][Full Text] [Related]
156. Hyaluronan-mediated CD44 interaction with p300 and SIRT1 regulates beta-catenin signaling and NFkappaB-specific transcription activity leading to MDR1 and Bcl-xL gene expression and chemoresistance in breast tumor cells. Bourguignon LYW; Xia W; Wong G J Biol Chem; 2009 Jan; 284(5):2657-2671. PubMed ID: 19047049 [TBL] [Abstract][Full Text] [Related]
157. Linkage of the BH4 domain of Bcl-2 and the nuclear factor kappaB signaling pathway for suppression of apoptosis. de Moissac D; Zheng H; Kirshenbaum LA J Biol Chem; 1999 Oct; 274(41):29505-9. PubMed ID: 10506215 [TBL] [Abstract][Full Text] [Related]
158. The role of TWEAK/Fn14 in cardiac remodeling. Ren MY; Sui SJ Mol Biol Rep; 2012 Nov; 39(11):9971-7. PubMed ID: 22752727 [TBL] [Abstract][Full Text] [Related]
159. Deletion of TNF-like weak inducer of apoptosis (TWEAK) protects mice from adipose and systemic impacts of severe obesity. Bennett G; Strissel KJ; DeFuria J; Wang J; Wu D; Burkly LC; Obin MS Obesity (Silver Spring); 2014 Jun; 22(6):1485-94. PubMed ID: 24616441 [TBL] [Abstract][Full Text] [Related]
160. Inhibition of the TWEAK/Fn14 pathway attenuates renal disease in nephrotoxic serum nephritis. Xia Y; Campbell SR; Broder A; Herlitz L; Abadi M; Wu P; Michaelson JS; Burkly LC; Putterman C Clin Immunol; 2012 Nov; 145(2):108-21. PubMed ID: 22982296 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]